Brazil Petrobras CFO: Planning For Share Offer By End-July (Fox News)
Brazil Petrobras CFO: Planning For Share Offer By End-July
Top Colombian rebel gets 20 years prison in U.S. (Reuters via Yahoo! News)
A top-ranking Colombian rebel was sentenced to more than 20 years in prison by a judge in New York on Friday for conspiring to import tons of cocaine into the United States.
Mendoza returns to Honduras squad after doping ban (Reuters via Yahoo! Sports)
Defender Sergio Mendoza, who completed a one-year doping suspension last month, was recalled by Honduras on Friday for a five-day World Cup training camp this month.
Guyana, Surinam and French Guiana: a guide for beginners (Daily Telegraph)
Chris Moss offers a guide to Guyana, Surinam and French Guiana, ahead of this year’s celebrations to mark the bicentenary of Latin America’s fight for independence.
NCAA: Fouls key in New Mexico State-Michigan State (AP via Yahoo! News)
Foul trouble could be a key in the closing minutes for Michigan State and New Mexico State. The Spartans’ Korie Lucious, Durrell Summers and Raymar Morgan all have four fouls, and the Aggies’ Jonathan Gibson and Jahmar Young have four each.
Gunmen block roads in Mexico’s drug-plagued north (Reuters via Yahoo! News)
Armed men likely linked to drug gangs blocked highways with trucks and buses in the northern Mexican city of Monterrey on Friday in an apparent attempt to hamper army operations near the U.S. border.
2 familiar faces face off for Colombian pres (AP via Yahoo! News)
Former Foreign Minister Noemi Sanin has defeated Colombian President Alvaro Uribe’s hand-picked successor for the Conservative Party’s presidential nomination in a close primary.
George Dohrmann: Michigan St. survives New Mexico State (Sports Illustrated)
SPOKANE, WASH — New Mexico State tried to beat Michigan State on Friday.
Valeant Acquiring Brazilian Firm, Factory (Investor’s Business Daily, Inc. via Yahoo! Finance)
Valeant Pharmaceuticals International said it would buy a Brazil-based generic and over-the-counter drugmaker for about $28 million to expand its generic and dermatology portfolio. Separately, Valeant will also buy a new 165,000 square-foot manufacturing plant approved to produce solids,
